Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer
1229.90 9.10 (0.75%)
NSE Mar 23, 2023 15:31 PM
Volume: 65,120
 

Result Updates Alert
Ajanta Pharma Ltd.    
01 Feb 2023
1229.90
0.75%

Ajanta Pharma announced Q3FY23 results 

  • Q3FY23:
    • Revenue from operations at Rs 972 crore against Rs 838 crore; up 16%.
    • EBITDA at Rs 170 crore against Rs 240 crore; EBITDA at 17% of revenue from operations.
    • Adjusted EBITDA stands at Rs 207 crore against Rs 240 crore; Adjusted EBITDA at 21% of revenue from operations. This is after adjusting forex derivative loss of Rs 37 crore included in other expenses with forex gain in other income.
    • Profit after tax at Rs 135 crore against Rs 192 crore; PAT at 14% of revenue from operations.
  • 9MFY23:
    • Revenue from operations at Rs 2,861 crore against Rs 2,471 crore, up 16%.
    • EBITDA at Rs 588 crore against Rs 723 crore; EBITDA at 21% of revenue from operations.
    • Adjusted EBITDA stands at Rs 631 crore against Rs 723 crore; Adjusted EBITDA at 22% of revenue from operations. This is after adjusting forex derivative loss of Rs 43 crore included in other expenses with forex gain in other income.
    • Profit after tax at Rs 466 crore against Rs 561 crore, PAT at 16% of revenue from operations.

Result PDF

Change YoY% Dec 2022 Sep 2022 Dec 2021
Total Revenue Qtr cr 16.8% 1006.70 978.45 861.94
Operating Profit Qtr Cr -29.2% 169.55 196.34 239.58
Net Profit Qtr Cr -29.9% 134.51 156.60 191.78
Basic EPS Qtr Rs -52.6% 10.50 12.22 22.16
More from Ajanta Pharma Ltd.
All Rapid Results
Recommended